Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Universe Pharmaceuticals INC UPC

Set alert

Price alert · UPC

All alert types
1.49 USD -0.05 -3.25%

At close · Oct 30

1.39 -0.10 -6.71%

After hours · Oct 30, 5:05 PM ET

Bid
1.45 × 5
Ask
1.50 × 4
1.45 Day range 1.67
1.49 52-week range 12.18
YTD
-60.89%
1 year
-68.30%
Open
1.50
Prev close
1.54
Mkt cap
7.49M
Vol
548.85K
Avg vol
808.24K
EPS
-1.38
P/E
0.00
Div yield
0.00%
More statistics
Low
1.45
High
1.67
Forward P/E
0.00
Beta
1.54
Short ratio
0.38
Inst. own
2.14%
Dividend
0.00
Ex-div date
50-d avg
3.10
200-d avg
27.45
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for UPC has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

0.61 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 5

Valuation

P/E -0.0×
FY 2018: 13.1×FY 2019: 13.2×FY 2020: 13.2×FY 2021: 4.1×FY 2022: -1.4×FY 2023: -0.5×FY 2024: -0.1×FY 2025: -0.0×
FY 2018 5y median -0.1× FY 2025
P/S 0.0×
FY 2018: 3.5×FY 2019: 3.0×FY 2020: 3.2×FY 2021: 1.0×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.1× FY 2025
P/B 0.0×
FY 2018: 10.3×FY 2019: 8.1×FY 2020: 4.8×FY 2021: 0.8×FY 2022: 0.3×FY 2023: 0.1×FY 2024: 0.0×FY 2025: 0.0×
FY 2018 5y median 0.1× FY 2025
P/FCF -0.0×
FY 2018: 23.1×FY 2019: 7.6×FY 2020: 16.5×FY 2021: -3.0×FY 2022: -8.6×FY 2023: 3.1×FY 2024: -0.1×FY 2025: -0.0×
FY 2018 5y median -0.1× FY 2025
EV/EBITDA 8.3×
FY 2018: 9.5×FY 2019: 9.7×FY 2020: 8.7×FY 2021: 3.0×FY 2022: -1.6×FY 2023: -1.1×FY 2024: 2.8×FY 2025: 8.3×
FY 2018 5y median 2.8× FY 2025
EV/Sales -1.4×
FY 2018: 3.4×FY 2019: 3.0×FY 2020: 3.0×FY 2021: 0.9×FY 2022: 0.3×FY 2023: 0.1×FY 2024: -0.9×FY 2025: -1.4×
FY 2018 5y median 0.1× FY 2025
FCF Yield -36963.7%
FY 2018: 4.3%FY 2019: 13.2%FY 2020: 6.1%FY 2021: -33.2%FY 2022: -11.7%FY 2023: 31.9%FY 2024: -1109.4%FY 2025: -36963.7%
FY 2018 5y median -33.2% FY 2025

Profitability

Gross Margin 35.3%
FY 2018: 47.0%FY 2019: 40.3%FY 2020: 45.9%FY 2021: 52.8%FY 2022: 54.5%FY 2023: 31.9%FY 2024: 26.4%FY 2025: 35.3%
FY 2018 5y median 35.3% FY 2025
Operating Margin -16.3%
FY 2018: 33.9%FY 2019: 29.4%FY 2020: 33.4%FY 2021: 28.3%FY 2022: -17.5%FY 2023: -10.9%FY 2024: -34.8%FY 2025: -16.3%
FY 2018 5y median -16.3% FY 2025
Net Margin -20.6%
FY 2018: 26.7%FY 2019: 22.7%FY 2020: 24.6%FY 2021: 23.6%FY 2022: -21.8%FY 2023: -19.1%FY 2024: -37.9%FY 2025: -20.6%
FY 2018 5y median -20.6% FY 2025
ROE -6.5%
FY 2018: 78.5%FY 2019: 61.0%FY 2020: 36.3%FY 2021: 19.2%FY 2022: -18.8%FY 2023: -15.6%FY 2024: -19.2%FY 2025: -6.5%
FY 2018 5y median -15.6% FY 2025
ROIC -4.5%
FY 2018: 62.7%FY 2019: 51.2%FY 2020: 33.3%FY 2021: 17.8%FY 2022: -13.9%FY 2023: -7.8%FY 2024: -15.0%FY 2025: -4.5%
FY 2018 5y median -7.8% FY 2025
ROA -5.3%
FY 2018: 27.1%FY 2019: 42.3%FY 2020: 26.2%FY 2021: 16.1%FY 2022: -14.7%FY 2023: -11.6%FY 2024: -12.8%FY 2025: -5.3%
FY 2018 5y median -11.6% FY 2025

Growth (YoY)

Revenue -22.4%
FY 2018: 0.0%FY 2019: 16.5%FY 2020: -7.6%FY 2021: 56.3%FY 2022: -16.3%FY 2023: -19.5%FY 2024: -28.7%FY 2025: -22.4%
FY 2018 FY 2025
Operating Income 63.6%
FY 2018: 0.0%FY 2019: 1.0%FY 2020: 5.1%FY 2021: 32.6%FY 2022: -151.7%FY 2023: 49.8%FY 2024: -127.4%FY 2025: 63.6%
FY 2018 FY 2025
EPS (diluted) 26.5%
FY 2018: 0.0%FY 2019: -0.7%FY 2020: 0.1%FY 2021: 65.7%FY 2022: -168.7%FY 2023: 29.5%FY 2024: -38.0%FY 2025: 26.5%
FY 2018 FY 2025
Free Cash Flow 45.3%
FY 2018: 0.0%FY 2019: 204.3%FY 2020: -53.8%FY 2021: -357.1%FY 2022: 91.0%FY 2023: 176.5%FY 2024: -1017.3%FY 2025: 45.3%
FY 2018 FY 2025

Financial Health

Current Ratio 4.1×
FY 2018: 1.2×FY 2019: 2.2×FY 2020: 2.9×FY 2021: 4.5×FY 2022: 3.2×FY 2023: 2.7×FY 2024: 2.5×FY 2025: 4.1×
FY 2018 5y median 3.2× FY 2025
Quick Ratio 3.9×
FY 2018: 0.8×FY 2019: 1.8×FY 2020: 2.6×FY 2021: 4.3×FY 2022: 3.0×FY 2023: 2.4×FY 2024: 2.5×FY 2025: 3.9×
FY 2018 5y median 3.0× FY 2025
Debt / Equity 0.2×
FY 2018: 0.3×FY 2019: 0.2×FY 2020: 0.1×FY 2021: 0.1×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.2×FY 2025: 0.2×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA 8.3×
FY 2018: -0.4×FY 2019: -0.1×FY 2020: -0.7×FY 2021: -0.3×FY 2022: 0.3×FY 2023: -0.1×FY 2024: 2.9×FY 2025: 8.3×
FY 2018 5y median 0.3× FY 2025
Interest Coverage -12.6×
FY 2018: 58.6×FY 2019: 75.4×FY 2020: 82.8×FY 2021: 134×FY 2022: -43.2×FY 2023: -22.5×FY 2024: -28.8×FY 2025: -12.6×
FY 2018 5y median -22.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2018: 3.1%FY 2019: 16.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018: 40.2%FY 2019: 211.9%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2018 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30